Health Trials

Treatment-Resistant Hypertension

2

Review clinical trials related to Treatment-Resistant Hypertension. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Effect of Renal Denervation on Bood Pressure in Patients on Hemodialysis

The RDN-HD Study is a prospective, single-center feasibility study. All patients included will undergo endovascular ultrasound-based RDN (no sham group, no blinding). The purpose of the RDN-HD Study is to demonstrate that ultrasound-based RDN is safe in patients with TRH and ESRD hemodialysis and reduces 24-h ambulatory BP.

Participants needed: 12
Trial details
Age: 18-99Biological sex: AllType: InterventionalSponsor: University of Erlangen-Nürnberg Medical SchoolUpdated: Sep 26, 2025Locations: 1
Eligibility criteria

Uncontrolled treatment resistant hypertension (despite intake of 3 different cla... [+4]

Episodes of sustained systolic and/or diastolic hypotension according to 24-h am... [+10]

Read more
Status: Recruiting

Endocalyx in Treatment Resistent Hypertension

The goal of this randomized, double-blind, placebo-controlled study is to assess whether the food supplement Endocalyx lowers blood pressure in patients with treatment resistant hypertension.

Participants needed: 64
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)Updated: Apr 23, 2025Locations: 1
Eligibility criteria

Treatment resistant hypertension defined as [+4]

Age <18 years. [+16]

Read more